SOURCE: Syneron Medical Ltd.

Syneron Medical Ltd.

June 04, 2009 14:30 ET

Syneron Medical to Present at the Gabelli & Company Small Cap Healthcare Conference and the Needham Growth Conference

YOKNEAM, ISRAEL--(Marketwire - June 4, 2009) - Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos™ combined-energy medical aesthetic devices, announced today that Syneron will participate in the Gabelli & Company Small Cap Healthcare Conference on Tuesday, June 9, 2009 and in the Needham Growth Conference on Wednesday, June 10, 2009, both in New York. Syneron CEO, Lou Scafuri, will present on behalf of Syneron at 9:30am ET in the Gabelli & Company Small Cap Healthcare Conference and at 8:00am ET in the Needham Growth Conference.

The presentations will be web cast live over the Internet and can be accessed through the 'Investor Overview' page on the Syneron's website at Please go to the website a few minutes early, as it may be necessary to download audio software to hear the presentations.

About Syneron

Syneron Medical Ltd. (NASDAQ: ELOS) manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented elos combined-energy technology of Bi-Polar Radio Frequency and Light. The Company's innovative elos technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications in the areas of facial applications, including skin rejuvenation, wrinkle reduction, and skin tightening, and body shaping, where the Company maintains a leadership position with its powerful VelaShape™ platform for circumferential reduction and cellulite treatment, and LipoLite™, Syneron's first device in the market for laser-assisted lipolysis. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. is located in Israel. Syneron has offices and distributors throughout the world, including North American Headquarters in Canada, North American Logistics Support Center in Irvine, CA, European Headquarters in Germany, and Asia-Pacific Headquarters in Hong Kong, which provide sales, service and support. Additional information can be found at

Syneron, the Syneron logo, and elos are trademarks of Syneron Medical Ltd. and may be registered in certain jurisdictions. Elos (Electro-Optical Synergy) is a proprietary technology of Syneron Medical. All other names are the property of their respective owners.

Contact Information

  • For more information, please contact:
    Judith Kleinman
    VP Investor Relations
    +972 (54) 646-1688
    email: Email Contact